NCT03600519View on ClinicalTrials.gov

Retinal Imaging Using NOTAL-OCT V2.5

CompletedOBSERVATIONAL

Enrollment

87

Participants

Timeline

Start Date

July 22, 2018

Primary Completion Date

February 18, 2019

Study Completion Date

January 1, 2020

Conditions

AMD

Interventions

DEVICE

NOTAL OCT V2.5

AMD Patients

Trial Locations (1)

3339123

Bnei Zion, Haifa

Sponsors

Lead Sponsor

Notal Vision Ltd.

All Listed Sponsors

lead

Notal Vision Ltd.

INDUSTRY

NCT03600519 - Retinal Imaging Using NOTAL-OCT V2.5 | Biotech Hunter | Biotech Hunter